Minoxidil NDC 72789-279

NDC codes

FDA NDC Directory

Product NDC (as listed)72789-279Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72789-0279Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72789-279-01	72789027901	100 TABLET in 1 BOTTLE, PLASTIC (72789-279-01)Marketed from Oct 7, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Minoxidil
Generic name (nonproprietary): minoxidil
Active ingredients: Minoxidil — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PD-Rx Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072709
Marketing start: Dec 14, 1995
Listing expires: Dec 31, 2027
Other FDA classes: Arteriolar Vasodilation (Physiologic effect)
Identifiers: Product ID 72789-279_56d2b6b3-9149-7192-e063-6394a90a72d3SPL ID 56d2b6b3-9149-7192-e063-6394a90a72d3SPL set ID f0dae476-8d0b-4d0c-a505-ad51bf27a1c8RxCUI 197986UNII 5965120SH1UPC 0372789279015
Pharmacologic class: Arteriolar Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472789027901 followed by a unit qualifier and the quantity

Package 72789-0279-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. At the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. Minoxidil reduced supine diastolic blood pressure by 20 mm Hg or to 90 mm Hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072709

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072709
Product	Strength	Form · route	Labeler	Product NDC
Minoxidil	Minoxidil 2.5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-278
Minoxidil	Minoxidil 10 mg/1	TabletOral	Bryant Ranch Prepack	63629-1086
Minoxidil	Minoxidil 2.5 mg/1	TabletOral	Sun Pharmaceutical Industries, Inc.	53489-386
Minoxidil	Minoxidil 10 mg/1	TabletOral	Sun Pharmaceutical Industries, Inc.	53489-387